VERA
Vera Therapeutics, Inc.
Vera Therapeutics, Inc. (VERA) has 2 SEC Form 4 filings (6 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 9, 2026.
Insiders have net sold $2.7M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Gary Barrera
- Employees:152
- HQ:Brisbane, CA, US
- IPO:2021-05-14
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.7M
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$3.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| PRESIDENT AND CEO | Sale | 46,250 | $2.0M | Jul 9 | SEC ↗ | |
Fordyce MarshallFirst filing | PRESIDENT AND CEO | Sale | 18,500 | $702K | Jun 24 | SEC ↗ |
Related companies
Vera Therapeutics, Inc. is in the Healthcare sector.